This article was originally published in The Gray Sheet
Electronically controlled, fully automated lancing system will be unveiled at the June American Diabetes Association Scientific Sessions in New Orleans. Designed to reduce pain associated with blood sample collection, the device will launch in "early 2004" in the U.S., Pelikan Technologies says. The firm gained 510(k) clearance April 23. A second-generation system that combines the lancet with glucose measurement capability is expected in 2005...
You may also be interested in...
Pelikan Technologies says its purchase of Inventus BioTec puts the company on track to obtain 510(k) clearance for a fully integrated lance and glucose monitor in 2006, with a U.S. launch the next year
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.